- Home
- FSEA vs VTVT Comparison
FSEA vs VTVT Comparison
Compare FSEA & VTVT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FSEA
- VTVT
- Stock Information
- Founded
- FSEA 1890
- VTVT 2015
- Country
- FSEA United States
- VTVT United States
- Employees
- FSEA N/A
- VTVT N/A
- Industry
- FSEA Savings Institutions
- VTVT Biotechnology: Pharmaceutical Preparations
- Sector
- FSEA Finance
- VTVT Health Care
- Exchange
- FSEA Nasdaq
- VTVT Nasdaq
- Market Cap
- FSEA 53.7M
- VTVT 47.9M
- IPO Year
- FSEA N/A
- VTVT 2015
- Fundamental
- Price
- FSEA $11.65
- VTVT $18.76
- Analyst Decision
- FSEA
- VTVT Strong Buy
- Analyst Count
- FSEA 0
- VTVT 2
- Target Price
- FSEA N/A
- VTVT $35.50
- AVG Volume (30 Days)
- FSEA 3.2K
- VTVT 2.7K
- Earning Date
- FSEA 11-07-2025
- VTVT 08-12-2025
- Dividend Yield
- FSEA N/A
- VTVT N/A
- EPS Growth
- FSEA N/A
- VTVT N/A
- EPS
- FSEA N/A
- VTVT N/A
- Revenue
- FSEA $14,095,000.00
- VTVT $17,000.00
- Revenue This Year
- FSEA N/A
- VTVT N/A
- Revenue Next Year
- FSEA N/A
- VTVT N/A
- P/E Ratio
- FSEA N/A
- VTVT N/A
- Revenue Growth
- FSEA 30.26
- VTVT N/A
- 52 Week Low
- FSEA $8.90
- VTVT $12.62
- 52 Week High
- FSEA $11.95
- VTVT $26.99
- Technical
- Relative Strength Index (RSI)
- FSEA 56.63
- VTVT 69.34
- Support Level
- FSEA $11.43
- VTVT $15.79
- Resistance Level
- FSEA $11.95
- VTVT $19.26
- Average True Range (ATR)
- FSEA 0.14
- VTVT 0.75
- MACD
- FSEA 0.01
- VTVT 0.37
- Stochastic Oscillator
- FSEA 50.00
- VTVT 65.15
About FSEA First Seacoast Bancorp Inc.
First Seacoast Bancorp Inc is a savings and loan holding company. Its business consists of taking deposits from the general public and investing those deposits, together with funds generated from operations and borrowings from the Federal Home Loan Bank, in one-to-four-family residential real estate loans, commercial real estate, and multi-family real estate loans, acquisition, development and land loans, commercial and industrial loans, home equity loans and lines of credit and consumer loans. The company generates revenue from financial instruments, such as loans, letters of credit, and investment securities, as well as revenue related to mortgage servicing activities, and bank-owned life insurance.
About VTVT vTv Therapeutics Inc.
vTv Therapeutics Inc is a clinical stage biopharmaceutical company focused on the development of orally administered treatments for metabolic and inflammatory diseases to minimize their long-term complications and improve the lives of patients. Its product pipeline include TTP399, TTP273, HPP737, HPP593, Azeliragon, HPP971, HPP3033, and TTP-RA.